GLENN LEVINE to Anticoagulants
This is a "connection" page, showing publications GLENN LEVINE has written about Anticoagulants.
Connection Strength
0.442
-
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022 10 11; 146(15):e205-e223.
Score: 0.143
-
The CHA2DS2-VASc score: Not as simple as it seems. Int J Cardiol. 2018 04 15; 257:92-96.
Score: 0.106
-
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Int J Cardiol. 2010 Mar 04; 139(2):123-33.
Score: 0.055
-
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9.
Score: 0.038
-
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial. J Am Coll Cardiol. 2003 Feb 05; 41(3):386-93.
Score: 0.037
-
The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes. Panminerva Med. 2002 Jun; 44(2):115-22.
Score: 0.035
-
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
Score: 0.028